All GLP-1 medications from FDA-registered 503B pharmacies Browse Products

Mounjaro injection pen with weekly timeline showing blood sugar improvements and appetite suppression results after 1 week of treatment
Mounjaro week 1 results: Blood sugar improvements and appetite changes.

Mounjaro Results After 1 Week: What to Expect

Mounjaro results after 1 week on the 2.5 mg starting dose. Covers blood sugar changes, appetite effects, weight expectations, and how to manage the first week of dual-agonist therapy.

By FormBlends Medical Team|Reviewed by FormBlends Clinical Review||

Medically Reviewed

Written by FormBlends Medical Team · Reviewed by FormBlends Clinical Review

In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

Mounjaro results after 1 week on the 2.5 mg starting dose. Covers blood sugar changes, appetite effects, weight expectations, and how to manage the first week of dual-agonist therapy.

Mounjaro results after 1 week are primarily felt in blood sugar stabilization and early appetite shifts. As a diabetes medication, Mounjaro (tirzepatide) begins influencing your glucose metabolism from the first injection. The 2.5 mg starting dose is introductory, but many patients with type 2 diabetes notice subtle improvements in their daily glucose readings within the first seven days. Here is what to expect.

Week 1 Breakdown

DayBlood Sugar EffectsAppetite and Side Effects
Day 1Drug absorbing. minimal glucose change yet.Injection is quick. Most patients feel normal.
Day 2-3Fasting glucose may improve by 10-20 mg/dL. Post-meal spikes start to blunt.Mild appetite reduction in 35-45% of patients. Possible light nausea.
Day 4-5More consistent glucose readings. Less variability between meals and overnight.Nausea typically improving. Smaller portions feel satisfying. Reduced snacking.
Day 6-7Weekly glucose pattern is noticeably smoother for many CGM users.Body adjusting. Ready for second injection. Most side effects have stabilized.

Blood Sugar Improvements

Mounjaro's dual GIP/GLP-1 mechanism attacks high blood sugar from multiple angles: enhanced insulin release, glucagon suppression, and slowed carbohydrate absorption. Even at the starting dose, patients with type 2 diabetes often see measurable changes. For a complete cost breakdown, see our best tirzepatide compounding pharmacies.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Mounjaro Results After 1 Week: What to Expect

What CGM Users Report

  • Tighter glucose range (fewer spikes above 180 mg/dL)
  • Lower average fasting glucose (often 10-25 mg/dL reduction)
  • Reduced time in hyperglycemia
  • More stable overnight glucose readings

HbA1c won't change measurably in one week. It reflects a 3-month average and requires time to show improvement. Plan to check HbA1c after 12 weeks on Mounjaro.

Weight Changes

Week 1 weight loss on Mounjaro is typically 0 to 3 pounds. The SURPASS trials showed average weight loss of 5 to 11 kg at 40 weeks depending on dose. The week 1 contribution is minimal.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.

Try the BMI Calculator →

For diabetes patients, weight loss is a welcome secondary benefit rather than the primary goal. Focus on blood sugar control first. the weight loss will follow as doses increase. Mounjaro weight loss timeline

Managing Other Diabetes Medications

If you're starting Mounjaro alongside existing diabetes treatments, week 1 medication management is critical:

  • Metformin: Usually unchanged. Safe to continue at your current dose
  • Sulfonylureas (glipizide, glimepiride): Your provider may reduce the dose to prevent hypoglycemia. Monitor blood sugar closely
  • Insulin: Dose reduction is often needed. Watch for low blood sugar, especially if you're on basal insulin
  • SGLT2 inhibitors: Typically safe to continue. Monitor hydration

Side Effects at 2.5 mg

  • Nausea: 12-18%. Mild and temporary. Peaks around day 3-4
  • Diarrhea: 8-12%. Usually resolves within the first week
  • Decreased appetite: Common and intended
  • Constipation: 5-8%. Increase water and fiber
  • Hypoglycemia: Uncommon with Mounjaro alone but possible if combined with insulin or sulfonylureas

Mounjaro side effects

Frequently Asked Questions

Is Mounjaro better than Ozempic for diabetes?

The SURPASS-2 trial[1] showed that Mounjaro produced greater HbA1c reductions and more weight loss than Ozempic (semaglutide 1 mg) at all tested doses. But both are highly effective. Your provider will consider insurance coverage, your metabolic profile, and tolerability when recommending one over the other. Mounjaro vs Ozempic

When will my HbA1c drop?

Meaningful HbA1c improvement takes 8-12 weeks at therapeutic doses (5 mg or higher). The full HbA1c benefit is typically seen by month 6. Don't judge Mounjaro by early HbA1c checks.

Can I eat normally during week 1?

Eat balanced meals with adequate protein. The reduced appetite from Mounjaro will naturally guide smaller portions. Avoid very large, heavy meals that worsen nausea. Focus on protein-rich foods and vegetables.

What if my blood sugar drops too low?

If you experience symptoms of low blood sugar (shakiness, sweating, confusion, rapid heartbeat), treat immediately with 15g of fast-acting carbohydrate (glucose tablets, juice, regular soda). Recheck in 15 minutes. Report episodes to your provider, who may adjust your other medications.

Medical References

  1. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. [PubMed | DOI]

Next Steps

Week 1 on Mounjaro sets the foundation. Blood sugar benefits start early and build with dose increases. Weight loss follows on a longer timeline. Stay consistent, monitor your glucose, and communicate with your provider about any concerns.

At FormBlends, we guide diabetes patients through every stage of Mounjaro treatment.

Starting Mounjaro? Get personalized support with a free assessment.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are reviewed by licensed physicians but are not a substitute for a personal medical consultation.

Written by FormBlends Medical Team

Board-certified endocrinologist specializing in metabolic medicine and GLP-1 therapeutics. Reviewed by FormBlends Clinical Review, clinical pharmacologist with expertise in compounded medications and peptide therapy.

Ready to get started?

Physician-supervised GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $299/month with free shipping.

Related Articles

Free Tools

Physician-designed calculators to support your weight loss journey.